Bharat Biotech News - Latest Updates & Headlines
Bharat Biotech launches India's only integrated cell, gene therapy, and viral production facility
Hyderabad, March 20: Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, announced today the launch of India's only vertically integrated, purpose-designed Cell and Gene Therapy (CGT) Infrastructure and Viral Vector Production Facility at Genome Valley in Telangana's Hyderabad expanding its expertise from vaccine innovation to leading-edge regenerative and personalised therapies that promise hope for millions, said a release.
Singapore President visits vaccine facility in Bhubaneswar
Bhubaneswar, January 19: Singapore President Tharman Shanmugaratnam visited the state-of-the-art Sapigen Biologix vaccine facility in Bhubaneswar, Odisha, which has been established with an investment of Rs 1,500 crore. The plant is expected to have the capacity to produce eight billion doses of vaccines per annum.
Odisha poised for new stage in development: Singaporean President Tharman
Bhubaneswar, January 18: Showcasing Odisha's potential for growth and development, Singapore President, Tharman Shanmugaratnam on Saturday highlighted the importance of working on the "enablers," such as vaccine manufacturers like Bharat Biotech, that would drive the state's progress.
Bharat Biotech's Dr. Krishna M Ella conferred with INSA India Fellowship
Hyderabad, Jan 8: Dr. Krishna Ell, co-founder and Executive Chairman of Bharat Biotech International, has been conferred the prestigious India Fellowship of the Indian National Science Academy (INSA) for the year 2025, the drug maker said on Tuesday.